Table 1.

Clinico-pathological features of the patient population and outcome.

Parameter	Number (%)
Patients	248
Spots	1,632 (at least three for each patient)
Age	< 40 y old: 18 patients (7%)
	40–50 y old: 80 patients (32%)
	51–70 y old: 121 (49%)
	> 70 y old: 29 patients (12%)
Menopause	110 patients (44%)
Estrogen receptor status	pos ≥ 10: 165 patients (66%)
Progesterone receptor status	pos ≥ 10%: 108 patients (44%)
HER2 status	0: 104 patients (55%)
	2+: 18 patients (9%)
	3+: 68 patients (36%)
	Missing: 58 patients
Nuclear grade	1: 18 patients (7%)
	2: 108 patients (44%)
	3: 122 patients (49%)
pN status	pN0 : 243 patients (98%)
	pN1mi : 2 patients (1%)
	pN1a : 3 patients (1%)
Presence of a microinfiltration	49 patients (20%)
Adjuvant treatment	No adjuvant therapy: 111 patients (45%)
	RT alone: 36 patients
	Hormonal treatment alone: 22 patients
	RT + hormonal treatment: 65 patients
	CT ± RT±hormonal treatment: 14 patients
Total relapses)	26 patients (10%)
Ipsilateral DCIS relapse	7 patients (27%)
Ipsilateral invasive BC relapse	3 patients (12%)
Contralateral DCIS relapse	11 patients (42%)
Contralateral invasive BC relapse	5 patients (19%)

Abbreviations: CT, chemotherapy; RT, radiotherapy; BC, breast cancer.